4.6 Editorial Material

Polygenic risk scores and prostate cancer screening: a recipe for more overdiagnosis?

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk

Burcu F. Darst et al.

Summary: The study revealed that the risk of prostate cancer from rare variants could vary based on an individual's genetic profile of common risk variants. Therefore, to comprehensively assess genetic risk of prostate cancer, it is crucial to consider both rare and common variants.

EUROPEAN UROLOGY (2021)

Article Genetics & Heredity

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fredrick R. Schumacher et al.

NATURE GENETICS (2018)

Review Urology & Nephrology

Observational studies and the natural history of screen-detected prostate cancer

Peter C. Albertsen

CURRENT OPINION IN UROLOGY (2015)

Article Medicine, General & Internal

Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study

Andrew J. Vickers et al.

BMJ-BRITISH MEDICAL JOURNAL (2010)

Article Medicine, General & Internal

Screening and Prostate-Cancer Mortality in a Randomized European Study

Fritz H. Schroeder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)